Literature DB >> 22326451

Chondrosarcoma of the scapula secondary to radiodermatitis.

David Pescador1, Juan Blanco, Carolina Corchado, Marcelo Jiménez, Gonzalo Varela, German Borobio, María Asunción Gómez.   

Abstract

INTRODUCTION: The scapula is one of the most common locations for chondrosarcomas. They may have a primary or secondary origin, and they can be due to a degeneration of benign lesions or be secondary to radiotherapy. The surgical treatment presents good survival rates, if safety margins are preserved. PRESENTATION OF CASE: We present the case of a chondrosarcoma of the scapula secondary to a radiodermatitis that required a modified total scapulectomy with a latissimus dorsi flap. DISCUSSION AND
CONCLUSION: Operations that respect or try to preserve the function of the upper limb must be taken into consideration in tumors of the pectoral girdle. Copyright Â
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22326451      PMCID: PMC3282252          DOI: 10.1016/j.ijscr.2011.11.009

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  9 in total

1.  Irradiation-induced chondrosarcoma. A case report.

Authors:  J E Fitzwater; H E Cabaud; G H Farr
Journal:  J Bone Joint Surg Am       Date:  1976-10       Impact factor: 5.284

2.  Interscapulo-thoracic resection for malignant tumors of the shoulder joint region. 1928.

Authors:  B E Linberg
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

3.  The functional and oncological results after scapulectomy for scapular tumours: 2-16-year results.

Authors:  N Mayil Vahanan; P Mohanlal; J C Bose; R Gangadharan; V Karthisundar
Journal:  Int Orthop       Date:  2006-10-17       Impact factor: 3.075

4.  Constrained total scapula reconstruction after resection of a high-grade sarcoma.

Authors:  James C Wittig; Jacob Bickels; Felasfa Wodajo; Kristen L Kellar-Graney; Martin M Malawer
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

5.  Chondrosarcoma of the scapula: long-term oncologic outcome.

Authors:  Rajeev Pant; Alan W Yasko; Valerae O Lewis; Kevin Raymond; Patrick P Lin
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

6.  Limb sparing surgery for bone tumours of the shoulder girdle: the oncological and functional results.

Authors:  Qiang Yang; Jianmin Li; Zhiping Yang; Xin Li; Zhenfeng Li
Journal:  Int Orthop       Date:  2009-08-23       Impact factor: 3.075

7.  Oncologic and functional outcome of scapular chondrosarcoma.

Authors:  Anthony M Griffin; Mahmood Shaheen; Robert S Bell; Jay S Wunder; Peter C Ferguson
Journal:  Ann Surg Oncol       Date:  2008-05-28       Impact factor: 5.344

8.  Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.

Authors:  Murat Altay; Kenan Bayrakci; Yusuf Yildiz; Selim Erekul; Yener Saglik
Journal:  J Orthop Sci       Date:  2007-09-28       Impact factor: 1.601

9.  Total scapulectomy and constrained reverse total shoulder reconstruction for a Ewing's sarcoma.

Authors:  Andreas F Mavrogenis; Dimitrios P Mastorakos; Georgios Triantafyllopoulos; Vasileios I Sakellariou; Evanthia C Galanis; Panayiotis J Papagelopoulos
Journal:  J Surg Oncol       Date:  2009-12-01       Impact factor: 3.454

  9 in total
  12 in total

1.  Sarcomatous Transformation of Recurrent Scapular Osteochondroma in a Patient with the Hereditary Multiple Osteochondromas: A Case Report and Literature Review.

Authors:  Sadia Sajid; Amman Yousaf; Usman Nabi; Amir Shahbaz; Umar Amin
Journal:  Cureus       Date:  2019-12-06

2.  Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the α v β 3 Integrin and the PKC δ , c-Src, and AP-1 Signaling Pathways.

Authors:  Chi-Ming Wu; Te-Mao Li; Tzu-Wei Tan; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-22       Impact factor: 2.629

3.  Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.

Authors:  Hsiang-Ping Lee; Chih-Yang Lin; Jhao-Sheng Shih; Yi-Chin Fong; Shih-Wei Wang; Te-Mao Li; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2015-11-03

4.  MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.

Authors:  Jingyuan Li; Lijuan Wang; Zongzhi Liu; Chao Zu; Fanfan Xing; Pei Yang; Yongkang Yang; Xiaoqian Dang; Kunzheng Wang
Journal:  Oncotarget       Date:  2015-09-22

5.  Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells.

Authors:  Chih-Yang Lin; Sunny Li-Yun Chang; Yi-Chin Fong; Chin-Jung Hsu; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2013-07-25       Impact factor: 5.923

6.  β5 integrin up-regulation in brain-derived neurotrophic factor promotes cell motility in human chondrosarcoma.

Authors:  Chih-Yang Lin; Hui-Jye Chen; Te-Mao Li; Yi-Chin Fong; Shan-Chi Liu; Po-Chun Chen; Chih-Hsin Tang
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

7.  Malawer limb salvage surgery for the treatment of scapular chondrosarcoma.

Authors:  Fei Chang; Guang-Yao Liu; Qiao Zhang; Gang Lin; Hong Huang; De-Sheng Duan; Jin-Cheng Wang
Journal:  World J Surg Oncol       Date:  2014-06-30       Impact factor: 2.754

8.  Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.

Authors:  Huey-En Tzeng; An-Chen Chang; Chun-Hao Tsai; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2016-06-21

9.  Chondrosarcoma of the patella: A case report.

Authors:  Conglin Ye; Zhiping Luo; Jin Zeng; Min Dai
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

10.  Latissimus dorsi rotational flap combined with a custom-made scapular prosthesis after oncological surgical resection: a report of two patients.

Authors:  Giovanni Beltrami; Gabriele Ristori; Guido Scoccianti; Angela Tamburini; Rodolfo Capanna; Domenico Campanacci; Marco Innocenti
Journal:  BMC Cancer       Date:  2018-10-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.